Compare NVNO & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVNO | VVOS |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 17.7M |
| IPO Year | N/A | 2020 |
| Metric | NVNO | VVOS |
|---|---|---|
| Price | $0.36 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 417.4K | 129.8K |
| Earning Date | 02-27-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,317,000.00 |
| Revenue This Year | N/A | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.76 |
| 52 Week Low | $0.30 | $1.93 |
| 52 Week High | $5.62 | $7.95 |
| Indicator | NVNO | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 44.53 | 51.08 |
| Support Level | $0.35 | $1.94 |
| Resistance Level | $0.39 | $2.69 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 52.36 | 38.67 |
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.